Cite
HARVARD Citation
Guillo, L. et al. (2023). Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Digestive and liver disease. 55 (1), pp. 61-68. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guillo, L. et al. (2023). Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Digestive and liver disease. 55 (1), pp. 61-68. [Online].